| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.25 | 0.4 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.4 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.4 |